Cost effectiveness of lanthanum carbonate in chronic kidney disease patients in Spain before and during dialysis

Blanca Gros (), Antonio Galán (), Emilio González-Parra (), Jose Herrero (), Maria Echave (), Stefan Vegter (), Keith Tolley () and Itziar Oyagüez ()

Health Economics Review, 2015, vol. 5, issue 1, 1-9

Abstract: LC is a cost-effective second line treatment of hyperphosphatemia in CKD patients irrespective of dialysis status in Spain. Copyright Gros et al. 2015

Keywords: Hyperphosphatemia; Calcium binders; Lanthanum carbonate; Predialysis; Dialysis (search for similar items in EconPapers)
Date: 2015
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://hdl.handle.net/10.1186/s13561-015-0049-3 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:hecrev:v:5:y:2015:i:1:p:1-9:10.1186/s13561-015-0049-3

Ordering information: This journal article can be ordered from
http://www.springer.com/journal/13561

DOI: 10.1186/s13561-015-0049-3

Access Statistics for this article

Health Economics Review is currently edited by J. Matthias Graf von der Schulenburg

More articles in Health Economics Review from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().